AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E- EPS (ttm)-2.24 Insider Own0.80% Shs Outstand60.20M Perf Week16.15%
Market Cap585.75M Forward P/E- EPS next Y-1.05 Insider Trans5.21% Shs Float35.64M Perf Month37.48%
Income-132.30M PEG- EPS next Q-0.27 Inst Own51.50% Short Float / Ratio11.18% / 5.75 Perf Quarter40.18%
Sales- P/S- EPS this Y-53.00% Inst Trans-6.74% Short Interest3.99M Perf Half Y275.71%
Book/sh-0.21 P/B- EPS next Y48.00% ROA-68.50% Target Price11.80 Perf Year8.92%
Cash/sh1.69 P/C5.50 EPS next 5Y15.00% ROE-449.70% 52W Range1.05 - 10.02 Perf YTD14.85%
Dividend- P/FCF- EPS past 5Y-5.70% ROI- 52W High-7.39% Beta1.56
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin- 52W Low783.81% ATR0.79
Employees66 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)64.51 Volatility9.68% 11.67%
OptionableYes Debt/Eq- EPS Q/Q10.90% Profit Margin- Rel Volume1.38 Prev Close10.00
ShortableYes LT Debt/Eq- EarningsNov 09 BMO Payout- Avg Volume692.91K Price9.28
Recom1.90 SMA2022.91% SMA5043.16% SMA20065.28% Volume955,209 Change-7.20%
Nov-30-22Upgrade Jefferies Hold → Buy $6.50 → $11
Aug-10-22Downgrade Jefferies Buy → Hold $6 → $8
Jul-28-22Resumed Craig Hallum Buy $15.50 → $12
May-26-22Downgrade Stifel Buy → Hold $9 → $2
Sep-23-21Initiated Needham Buy $17
Jul-31-20Initiated Oppenheimer Outperform $19
Jul-21-20Initiated SVB Leerink Outperform $17
Jun-30-20Initiated H.C. Wainwright Buy $15
Apr-03-20Initiated Jefferies Buy $14
Mar-12-20Initiated Stifel Buy $14
Show Previous Ratings
Dec-01-22 04:05PM
Nov-26-22 07:49AM
Nov-22-22 08:00AM
Nov-21-22 04:05PM
02:32PM
08:40AM Loading…
08:40AM
Nov-18-22 02:45PM
Nov-10-22 08:00AM
Nov-09-22 07:30AM
Nov-07-22 04:05PM
Nov-02-22 04:05PM
Oct-24-22 04:05PM
Oct-16-22 10:25AM
Sep-22-22 08:00AM
Sep-07-22 08:00AM
08:00AM Loading…
Aug-09-22 08:00AM
07:00AM
Aug-05-22 09:55AM
Aug-02-22 08:00AM
Jul-19-22 07:00AM
Jun-30-22 08:09AM
Jun-29-22 04:05PM
Jun-03-22 08:00AM
Jun-02-22 08:00AM
06:07AM
May-26-22 09:09AM
May-19-22 08:00AM
May-18-22 08:00AM
May-09-22 10:05AM
07:00AM
08:00AM Loading…
May-02-22 08:00AM
Apr-28-22 08:00AM
Apr-26-22 11:38AM
07:30AM
Apr-25-22 08:00AM
Apr-06-22 08:00AM
Mar-22-22 08:00AM
Mar-17-22 07:00AM
Mar-14-22 04:30PM
08:00AM
Mar-11-22 07:00AM
Mar-10-22 04:30PM
Mar-01-22 07:00AM
Feb-22-22 11:40AM
Feb-14-22 07:00AM
Feb-10-22 07:00AM
Dec-08-21 08:30AM
Nov-24-21 04:19AM
Nov-22-21 08:00AM
Nov-09-21 08:00AM
Nov-08-21 03:30PM
08:00AM
Nov-04-21 03:07AM
Nov-01-21 04:37PM
08:00AM
Oct-29-21 05:38PM
Oct-26-21 01:32AM
Oct-20-21 07:17PM
Oct-19-21 08:00AM
Oct-18-21 07:02PM
02:12PM
08:18AM
07:02AM
Oct-15-21 05:00PM
Oct-03-21 09:00AM
Sep-29-21 08:32AM
Sep-20-21 08:00AM
Sep-03-21 09:32AM
Sep-02-21 08:00AM
Aug-26-21 06:14AM
Aug-16-21 08:00AM
Aug-09-21 02:30PM
08:00AM
Aug-02-21 08:00AM
Jul-07-21 08:00AM
Jun-27-21 03:36AM
Jun-09-21 09:00AM
Jun-03-21 08:00AM
Jun-02-21 08:00AM
May-25-21 08:00AM
May-13-21 02:00AM
May-10-21 06:00PM
08:00AM
06:45AM
Apr-29-21 08:00AM
Apr-19-21 07:05AM
Apr-17-21 08:00AM
Apr-08-21 08:00AM
Mar-29-21 01:22AM
Mar-18-21 08:00AM
Mar-09-21 03:00PM
07:00AM
05:30AM
Mar-04-21 08:00AM
Mar-02-21 08:00AM
Mar-01-21 12:10PM
08:00AM
Feb-25-21 08:00AM
Feb-23-21 06:20PM
Feb-17-21 08:00AM
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCHUGH THOMAS SChief Financial OfficerNov 29Buy7.805,00039,00076,500Nov 30 04:01 PM
Ende Eric JDirectorNov 22Buy7.8020,000156,050154,900Nov 23 04:01 PM
Glass Geoffrey MichaelDirectorJun 01Buy2.1445,00096,30045,000Jun 02 04:02 PM
Ende Eric JDirectorJun 01Buy2.2720,00045,496134,900Jun 01 06:59 PM
Ende Eric JDirectorMay 31Buy2.1615,00032,394114,900Jun 01 06:59 PM
Thornton Peter J.DirectorMay 27Buy1.6950,00084,50083,055May 31 07:12 AM
Divis Gregory JChief Executive OfficerMay 27Buy2.0550,000102,500149,100May 31 07:13 AM
Ende Eric JDirectorMay 27Buy2.4515,00036,74799,900May 31 07:14 AM
MCHUGH THOMAS SChief Financial OfficerMay 27Buy2.1450,000106,89571,500May 31 07:15 AM
Palczuk LindaDirectorMay 27Buy1.6010,00016,00047,900May 31 07:17 AM